Generali Asset Management’s Marvell Technology MRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.4M Buy
101,900
+43,468
+74% +$8.72M 0.55% 40
2026
Q1
$5.79M Sell
58,432
-15,765
-21% -$1.32M 0.12% 169
2025
Q4
$6.31M Buy
74,197
+17,976
+32% +$1.57M 0.13% 151
2025
Q3
$4.73M Sell
56,221
-18,965
-25% -$1.4M 0.1% 184
2025
Q2
$5.82M Buy
75,186
+10,539
+16% +$658K 0.13% 159
2025
Q1
$3.98M Buy
64,647
+5,345
+9% +$519K 0.1% 203
2024
Q4
$6.55M Buy
+59,302
New +$5.51M 0.17% 130

Other funds holding MRVL

Generali Asset Management's MRVL Position: Q2 2026 in Review

Generali Asset Management increased its Marvell Technology (MRVL) stake by 74% in Q2 2026, buying an estimated $8.72M and bringing the position to 101,900 shares worth $30.4M. The position accounts for 0.55% of the portfolio, ranked #40.

Generali Asset Management first reported a position in MRVL in Q4 2024 and has held it in 7 quarters since. 2,203 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

  • Generali Asset Management held 101,900 shares of Marvell Technology worth $30.4M as of Q2 2026.
  • Generali Asset Management bought 43,468 Marvell Technology shares in Q2 2026, an estimated $8.72M.
  • Marvell Technology made up 0.55% of Generali Asset Management's portfolio in Q2 2026, its #40 holding.
  • Generali Asset Management first reported a position in Marvell Technology in Q4 2024 and has held it in 7 quarters since.
  • 2,203 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.